Welcome to Capsule, where we’ll give you your weekly dose of what to watch out for in the health-care space. Each Monday reporters Jacquie Lee and Madison Alder get you prepped for the week’s hottest health-care topics.
Madison: It feels like Gilead Sciences is always making waves in the health world recently. Its latest move challenging the government’s patents for use of Gilead’s Truvada as HIV prevention could end up having a ripple effect. Shortly after President Donald Trump announced his plan to end HIV by 2030, advocates argued Gilead has been infringing government-held patents for HIV prevention for years. ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.